Jeffrey Crawford
Hematology & Oncology · Durham, NCNPI 1023191277
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $81,250 of the $125,007 with a category attached, or 65.0%. 16 manufacturers reported payments, led by Pfizer at 34.9% of the total. Reporting peaked in 2019 at $43,011 and has fallen 93.0% since, to $3,004 in 2025. Among hematology & oncology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $1923.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$44K
- Astrazeneca UK Limited$15K
- AstraZeneca$13K
- Jazz Pharmaceuticals Inc.$10K
- Sandoz$10K
- G1 Therapeutics, Inc.$10K
- plus $24K from 10 others
Across 168 payments — averaging $4518.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$478K
- Pfizer$193K
- Helsinn Healthcare SA$58K
- Amgen$19K
- Genentech, Inc.$8K
- Pharmacosmos Therapeutics Inc.$2K
- plus $96 from 1 others
What the payments were for
- Consulting fees$81,25065%
- Speaking & faculty fees$14,21011%
- Travel & lodging$27,83322%
- Food & beverage$1,6901%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 22 | $43,660 |
| Astrazeneca UK Limited | 3 | $14,649 |
| AstraZeneca | 14 | $12,796 |
| Jazz Pharmaceuticals Inc. | 1 | $10,240 |
| Sandoz | 1 | $9,900 |
| G1 Therapeutics, Inc. | 2 | $9,750 |
| GSK | 2 | $5,244 |
| Spectrum Pharmaceuticals Inc. | 9 | $4,578 |
| Partner Therapeutics, Inc. | 2 | $3,800 |
| Merck | 2 | $3,250 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,560 |
| Coherus Oncology, Inc. | 1 | $2,013 |
| Seagen Inc. | 1 | $1,804 |
| Janssen Scientific Affairs, LLC | 1 | $500 |
| Dova Pharmaceuticals | 2 | $224 |
| Medtronic | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$125,007 in reported general payments places this provider in the 95th percentile of 358 hematology & oncology providers in North Carolina.
Other hematology & oncology in Durham
- Michael MorseDurham$2.6M
- Phillip FebboDurham$749K
- Matthew McKinneyDurham$277K
- Taewoong ChoiDurham$207K
- Ivy AltomareDurham$164K
- Carlos de CastroDurham$124K
- Joseph MooreDurham$97K
- Ammon FagerDurham$56K
- Jameel MuzaffarDurham$31K
- Jeremy ForceDurham$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.